About VLP BIOTECH, INC.
VLP Biotech development of epitope-focused vaccines. Our technology enables elicitation of robust antibody and CD4 T cell responses to defined protein regions. Our technology is suited for carbohydrate or other target conjugation.
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to VLP BIOTECH, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.